Targeting glutamate to treat schizophrenia: lessons from recent clinical studies
Crossref DOI link: https://doi.org/10.1007/s00213-016-4318-6
Published Online: 2016-05-23
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Beck, Katherine
Javitt, Daniel C
Howes, Oliver D
Funding for this research was provided by:
Maudsley Charity (666)
Brain and Behavior Research Foundation, and Wellcome Trust (094849/Z/10/Z)
Medical Research Council-UK (MC-A656-5QD30)
Text and Data Mining valid from 2016-05-23